Changing Lives
in Real Time

We are transforming pediatric healthcare through the power of Rapid Precision Medicine™.


Genomic Research

We’re innovating to expedite personalized treatment of rare genetic disease.


Advancing Rapid
Precision Medicine™

We’re setting a new standard of care for newborns and children with rare undiagnosed diseases.

Dr. Sweeney checks on a baby

Join Our Team

We're hiring for clinical, research, bioinformatics, and administrative positions.

Photo of smiling lab staff
Photo of smiling lab staff
previous arrow
next arrow


Baby Fitz in the RCHSD NICU
Media Coverage

Baby Fitz was born without an immune system. His treatment offers hope for curing rare diseases.

Babies with Fitz’s condition, commonly known as “bubble boy disease,” rarely survive to toddlerhood. He became one of the first babies anywhere to get a specific diagnosis within days of birth and an experimental therapy several months later that appears to have worked.

Read More
Project Baby Bear included in AJHG Top 10 Genomic Papers for 2021
Media Coverage

Genomics and Precision Medicine 2021: Progress in Implementation, A Focus on Health Equity, and a New Public Health Initiative

In 2021, the Genomic Medicine Working Group of the National Advisory Council for Human Genome Research of NHGRI identified its ten most significant peer-reviewed studies for 2021.

Read More
Genomics News
Media Coverage

2021 Year in Review: Whole-genome sequencing of critically ill babies proves its worth

While it is safe to say that RCIGM has sufficiently proven its ability to identify the genetic variants driving many of these life-threatening rare conditions, it is now on a mission to bring its method of diagnosing sick babies to health systems across the country.

Read More



NTRK Fusions in Pediatric Population: A Model to Drive Precision Medicine in Rare Tumors

Wednesday February 23, 2022 | 3pm PST


  • Alanna Church, MD Assistant Professor of Pathology, Harvard Medical School and Associate Director, Laboratory for Molecular Pediatric Pathology (LaMPP), Dana-Farber Cancer Institute
  • Noah Federman, MD Director, UCLA Clinical and Translational Research Center and Director, UCLA Pediatric Bone and Soft Tissue Sarcoma Program UCLA Jonsson Comprehensive Cancer Center

*Free Registration is required


Frontiers in Pediatric Genomic Medicine Conference 2022

Tuesday April 26, 2022 | Wednesday, April 27, 2022

Save the date for our virtual annual Frontiers in Pediatric Genomic Medicine Conference, coming April 26-27, 2022 to a computer screen near you.

1 / 2
View All Events

Join Us in Transforming
Pediatric Healthcare

Rapid Precision Medicine™ is here now. We are setting the standard for pediatric critical care by breaking barriers to expand access to genomically-informed, personalized care nationwide. We offer many opportunities to collaborate with as we work to save and improve lives.